Nwagwu Margaret O, Baines Helen, Kerr Jeffrey B, Ebling Francis J P
School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Reprod Biol Endocrinol. 2005 Sep 21;3:48. doi: 10.1186/1477-7827-3-48.
Testicular development is arrested in the hypogonadal (hpg) mouse due to a congenital deficiency in hypothalamic gonadotropin-releasing hormone (GnRH) synthesis. Chronic treatment of male hpg mice with estradiol induces FSH synthesis and secretion, and causes testicular maturation and qualitatively normal spermatogenesis. As estradiol negative feedback normally inhibits FSH production in the male, this study tested whether this paradoxical response to estradiol in the male hpg mouse might be due to inadequate masculinisation or incomplete defeminization in the neonatal period. Previous studies have demonstrated that treatment of hpg mice with testosterone propionate in the immediate neonatal period is necessary to allow full reproductive behaviors to be expressed following suitable endocrine stimulation at adult ages.
Hpg mice were treated with 100 mug testosterone propionate or vehicle on postnatal day 2. At 35 days of age, subgroups of these mice were treated with silastic implants containing estradiol or cholesterol. Reproductive behavior was scored in tests with steroid-primed female mice, then testicular development was assessed histologically, and measures of pituitary FSH content made at 85 days of age.
The neonatal testosterone propionate treatment successfully defeminized female litter mates, as revealed by impaired vaginal opening and deficiencies in lordosis behavior, and it allowed appropriate male reproductive behavior to be expressed in a proportion of the hpg males when tested at an adult age. However, neonatal androgen supplementation did not block or even reduce the subsequent actions of estradiol in increasing pituitary FSH content, nor did it affect the ability of estradiol to induce qualitatively normal spermatogenesis.
The ability of the hpg male to show a "female" neuroendocrine response to estradiol is not a result of inadequate androgenization during neonatal development, and thus the actions of estradiol revealed in this rodent model are not an artefact of incomplete sexual differentiation, but reflect a physiological role of estradiol occurring during a specific early temporal window of male reproductive development.
性腺功能减退(hpg)小鼠的睾丸发育停滞,原因是下丘脑促性腺激素释放激素(GnRH)合成先天性缺陷。用雌二醇长期治疗雄性hpg小鼠可诱导卵泡刺激素(FSH)的合成与分泌,并使睾丸成熟以及精子发生在质量上正常。由于雌二醇负反馈通常会抑制雄性体内FSH的产生,本研究检验了雄性hpg小鼠对雌二醇这种矛盾反应是否可能是由于新生儿期雄性化不足或雌性化未完全消除所致。先前的研究表明,在新生儿期即刻用丙酸睾酮治疗hpg小鼠,对于成年后在适当的内分泌刺激下充分表达生殖行为是必要的。
在出生后第2天,给hpg小鼠注射100微克丙酸睾酮或赋形剂。在35日龄时,将这些小鼠的亚组用含雌二醇或胆固醇的硅橡胶植入物进行处理。在用类固醇预处理的雌性小鼠进行的试验中对生殖行为进行评分,然后通过组织学评估睾丸发育情况,并在85日龄时测定垂体FSH含量。
新生儿期丙酸睾酮治疗成功地使雌性同窝仔鼠雌性化减弱,表现为阴道开口受损和脊柱前凸行为缺陷,并且在成年期测试时,使一部分hpg雄性小鼠能够表现出适当的雄性生殖行为。然而,新生儿期补充雄激素并未阻断甚至未降低随后雌二醇在增加垂体FSH含量方面的作用,也未影响雌二醇诱导质量上正常精子发生的能力。
hpg雄性小鼠对雌二醇表现出“雌性”神经内分泌反应的能力并非新生儿期雄激素化不足的结果,因此在该啮齿动物模型中揭示的雌二醇作用并非不完全性分化的假象,而是反映了在雄性生殖发育特定早期时段雌二醇的生理作用。